Skip to main content
Clinical Trials/NCT01942239
NCT01942239
Completed
Not Applicable

Real-time Continuous Glucose Monitoring Reduces Duration of Hypoglycemia Episodes in Very Low Birth Weight Neonates

University Hospital, Tours1 site in 1 country48 target enrollmentDecember 1, 2008
ConditionsHypoglycemia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hypoglycemia
Sponsor
University Hospital, Tours
Enrollment
48
Locations
1
Primary Endpoint
number of hypoglycemia episodes
Status
Completed
Last Updated
4 months ago

Overview

Brief Summary

Hypoglycemia is frequent in very low birth weight (VLBW) neonates and compromises their neurological outcome. The aim of this study was to compare real-time continuous glucose monitoring system (RT-CGMS) to standard method by intermittent capillary blood glucose testing in detecting and managing hypoglycemia. The investigators calculated a number of 48 neonates to be randomized between 2 ways of glucose level monitoring for their 3 first days of life : either by RT-CGMS (CGM-group), or by intermittent capillary glucose testing (IGM-group) associated with a blind-CGMS to detect retrospectively missed hypoglycemia. The investigators' hypothesis is that in the CGM group number and duration of hypoglycemia will be lower.

Registry
clinicaltrials.gov
Start Date
December 1, 2008
End Date
November 1, 2009
Last Updated
4 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Very low birth weight (VLBW) preterm infants (birth weight under 1500g) who were admitted before 24 hours of life in the Department of Neonatology of the University Hospital of Tours

Exclusion Criteria

  • a serious congenital abnormality,
  • a skin condition that contraindicated continuous glucose monitoring,
  • a transfer toward another hospital during the first days of life
  • an absence of parental agreement.

Outcomes

Primary Outcomes

number of hypoglycemia episodes

Time Frame: at the end of the first 3 days of life

hypoglycemia was defined as interstitial glucose level \<50 mg/dl; consecutive or \<30 min data points \<50 mg/dl were defined as a single episode of low glucose concentration.

Secondary Outcomes

  • duration of hypoglycemic episodes(after their 3 first days of life)

Study Sites (1)

Loading locations...

Similar Trials